Skip to content

The ELEGANT Trial: Elevate Transvaginal Mesh vs. Anterior Colporrhaphy

Safety and Efficacy of Transvaginal Mesh Colposuspension for Anterior Vaginal Prolapse: the Elevate vs. Anterior Colporrhaphy Trial

Status
Terminated
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01497171
Enrollment
5
Registered
2011-12-22
Start date
2011-11-30
Completion date
2013-05-31
Last updated
2014-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic Organ Prolapse

Keywords

Cystocele, Bladder prolapse, Anterior prolapse, Vaginal prolapse, Uterine prolapse, Urinary incontinence

Brief summary

This study is designed to compare the safety and efficacy of a commercially available mesh kit used for surgical repair of anterior vaginal wall prolapse with traditional suture repair surgery.

Detailed description

This is a multicenter, double blinded, randomized controlled trial, comparing Elevate® System with Interpro® Lite™, Anterior and Apical Prolapse Repair System (American Medical Systems) and Anterior Colporrhaphy (anterior suture repair) in women with symptomatic pelvic organ prolapse, who have opted to have surgical repair. The goals of the study are to compare both efficacy and safety of the two procedures and to compare the surgical impact of mesh and suture repairs on vaginal function. The principal investigator is from Mayo Clinic in Rochester, Minnesota. Mayo Clinic will serve as the data gathering and coordination site for this multicenter trial.

Interventions

PROCEDUREElevate Mesh

Transvaginal mesh repair of anterior vaginal prolapse

Traditional suture repair of anterior vaginal prolapse

Sponsors

American Medical Systems
CollaboratorINDUSTRY
Emanuel Trabuco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
FEMALE
Age
21 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Women with symptomatic pelvic organ prolapse who opt for a vaginal repair * Require both apical and anterior compartment repairs * Willing to return for follow-up visit * Understand and have signed informed consent to undergo randomization * Need both an apical and anterior repair * All trial participants who have a uterus will require a hysterectomy

Exclusion criteria

* Known or suspected vulvodynia * Known or suspected interstitial cystitis * History of chronic pelvic pain * Current pregnancy * Desire to maintain fertility * History of reconstructive pelvic surgery with synthetic mesh * History of radical pelvic surgery * History of pelvic radiation therapy * Currently undergoing treatment for a malignancy * Medically poor candidates for surgery

Design outcomes

Primary

MeasureTime frameDescription
Comparison of the Proportion of Subjects in Each Group, Who Achieve Anatomic Success at 12 Month Follow-up.12 monthsAnatomical success will be measured using a composite index including: lack of specific prolapse symptoms, no interval treatment and no observed prolapse beyond 1 cm from the hymen.

Countries

Germany, United States

Participant flow

Recruitment details

5 women were enrolled at the German site (St. Hedwig's). No subjects were enrolled at the US sites.

Participants by arm

ArmCount
Elevate Mesh
Transvaginal mesh repair of anterior vaginal prolapse
2
Anterior Colporrhaphy
Traditional suture repair of anterior vaginal prolapse
3
Total5

Baseline characteristics

CharacteristicElevate MeshAnterior ColporrhaphyTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
1 Participants2 Participants3 Participants
Age, Categorical
Between 18 and 65 years
1 Participants1 Participants2 Participants
Region of Enrollment
Germany
2 participants3 participants5 participants
Sex: Female, Male
Female
2 Participants3 Participants5 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 21 / 3
serious
Total, serious adverse events
0 / 20 / 3

Outcome results

Primary

Comparison of the Proportion of Subjects in Each Group, Who Achieve Anatomic Success at 12 Month Follow-up.

Anatomical success will be measured using a composite index including: lack of specific prolapse symptoms, no interval treatment and no observed prolapse beyond 1 cm from the hymen.

Time frame: 12 months

Population: No analysis was done due to early termination of the study.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026